Clinical Trials Directory

Trials / Sponsors / LimmaTech Biologics AG

LimmaTech Biologics AG

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old
Shigellosis
Phase 22025-04-07
CompletedA First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureu
Staphylococcus (S.) Aureus Infection
Phase 12025-01-07
Active Not RecruitingA Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine
Shigellosis
Phase 22024-11-12
Active Not RecruitingAssessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvova
Recurrent Vulvovaginal Candidiasis
Phase 1 / Phase 22023-12-06
CompletedSafety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
Klebsiella Pneumoniae Infection
Phase 1 / Phase 22021-07-05
CompletedA Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infant
Shigellosis
Phase 1 / Phase 22019-09-02
CompletedPhase I to Test a New Pneumococcal Vaccine
Pneumococcal Pneumonia, Pneumonia, Bacterial
Phase 12017-09-07
CompletedPhase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
Shigellosis
Phase 22015-12-01
CompletedSafety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
Shigellosis
Phase 12015-02-01